By John Halamka and Paul Cerrato - A recent report points out that providers are not taking the necessary steps to secure the mobile devices connected to their network.

By John Halamka and Paul Cerrato - A growing number of studies show that drug/gene interactions can influence how patients respond to specific medications. But there are barriers that prevent the full implementation of pharmacogenomic testing into routine clinical practice.

Mayo Clinic recently welcomed seven more healthcare startups to its accelerator program. In exchange for an equity position in each startup, Mayo Clinic gives young digital health companies the opportunity to refine their AI models using its deidentified data sets and subject matter experts.

By John Halamka and Paul Cerrato - Concerns about algorithmic bias and poor performance of the models have made many stakeholders more cautious about using these digital tools in patient care. That’s about to change.

Mayo Clinic Platform_Accelerate has announced its second cohort of health tech startups, including national and international businesses. The program will help seven companies develop and validate their artificial intelligence-driven health care products or solutions and advance their business plans.

We expect that someday many important diagnosis and treatment decisions will be made or augmented by AI applications. Today we are in the early stages of achieving that objective.

Hospitals are using AI, data analytics and machine learning to improve health outcomes, produce predictive clinical insights and improve patient care.

Mayo Clinic Platform Conference brought together leaders from government, academia, and industry to discuss the future of health care.

By John Halamka and Paul Cerrato - The daily headlines may suggest a dystopian future, but the evidence shows the world is actually becoming a healthier, safer place to live.